Immunotherapy is one of the hottest topics in cancer research. This year, focus at the ASCO Annual Meeting has been on a type of immunotherapy called PD-1 inhibitors. Learn how these drugs may help improve the treatment of head and neck, liver, and lung cancers.
A recent study shows that people who took a form of vitamin B3 called nicotinamide developed fewer non-melanoma skin cancers. In this podcast, Patricia A. Ganz, MD, discusses this study and what it means for people at risk for skin cancer.
In this podcast, experts discuss ASCO’s recent endorsement of ASTRO’s guideline for radiation therapy for non-small cell lung cancer.
First in this podcast series, Dr. Brian Rini shares his perspective on current and new approaches to kidney cancer treatment.
Get highlights of four studies that address ways to improve the care of men with prostate cancer. Results include the identification of a potential risk factor, better ways to select the best treatment option, and new insight into the debate over prostate-specific antigen (PSA) screening.
Dr. Neal Meropol and his colleagues created the video-based PRE-ACT program to answer questions and concerns patients have about participating in clinical trials. This tool is now available on Cancer.Net.
In this podcast, Dr. Smitha Krishnamurthi shares highlights of a new study about the connection between Vitamin D levels and colorectal cancer treatment.
Research presented this weekend will highlight three potential new approaches to the treatment of colorectal cancer.
In these two podcasts, Dr. Sundar Jagannath and Dr. Hope Rugo share the latest highlights in myeloma and breast cancer research.
In this podcast, Jeffrey S. Weber, MD, PhD, explains the recent ASCO statement on phase I clinical trials and why these studies are important treatment options to discuss with your doctor.